Amides

<p>3-Oxo-2-phenyl butanamide is an amphetamine that has been shown to be a potential marker for wastewater. 3-Oxo-2-phenyl butanamide is one of the many intermediates in the synthesis of amphetamine from phenylacetone and can be found in wastewater as an impurity. This compound has also been used as a marker for wastewater treatment malfunctioning. 3-Oxo-2-phenyl butanamide is excreted into the environment through urine, and its presence can be measured in water samples by gas chromatography/mass spectrometry or liquid chromatography/mass spectrometry.</p>

<p>Please enquire for more information about (3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl)-N-(2,5-dimethoxyphenyl)formamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>2,3-Diaminobenzamide is a synthetic aromatic compound that is used as a radiation stabilizer. It is also an effective antimicrobial agent with reactive properties against bacteria and fungi. 2,3-Diaminobenzamide has been shown to have anti-cancer properties and can be used to treat inflammatory diseases such as rheumatoid arthritis or ulcerative colitis. The intramolecular hydrogen bond between the amide group and the benzene ring in 2,3-diaminobenzamide contributes to its stability and biological activity.</p>

<p>2,2-diphenyl-N,N-dimethylpropeneamide (DPPA) is a disulfide compound that has photolytic, thermolytic and modelling properties. DPPA can be used to produce alkylcobalt complexes with various substituents at the α position of the phenyl ring. The lactam structure of DPPA has been shown to undergo thermolysis at temperatures of 250°C in a vacuum. Cinnamic acids have been shown to form lactams with DPPA as well as cinnamic acid derivatives. Molecular modelling studies have been conducted on 2,2-diphenyl-N,N-dimethylpropeneamide and its molecular interactions with styrene and amido groups.</p>

<p>Please enquire for more information about L-Leucine b-naphthylamide hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>L-Histidine beta-naphthylamide is an allosteric activator of the imidazole group of histidine. It has been shown to regulate sequences and functional groups in subtilisin. L-Histidine beta-naphthylamide binds to the benzyl ester and regulatory allosteric site on the enzyme, which is located between the active site and the substrate binding site. The binding of this molecule stabilizes a transition state intermediate that would otherwise be too reactive to form products.</p>

<p>N-(2-Fluorophenyl)-N-[4-(4-methyl-1,3-thiazol-2-yl)-1-(2-thiophen-3-ylethyl)piperidin-4-yl]propanamide is a drug that is used for the treatment of cancer. This drug is hydrophobic and has a molecular weight of 455. It has been shown to be effective in treating cancer cells by binding to the cell membrane and inhibiting the proliferation of these cells. N-(2-Fluorophenyl)-N-[4-(4-methyl-1,3-thiazol-2-yl)-1-(2-thiophen-3-ylethyl)piperidin]-4-- yl]propanamide also inhibits tumor growth by reducing extracellular matrix production and inducing apoptosis in cancer cells. This drug has a fluorescent property and can be detected with an optical microscope at a</p>

<p>Please enquire for more information about 2-((4-Methylphenyl)sulfonyl)-N-(((2-thienylcarbonylamino)thioxomethyl)amino)ethanamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Sodium diformylamide is a chemical compound that belongs to the class of amides. It has been shown to inhibit the activity of a number of enzymes including alkanoic acid, inorganic acid, and amide. It has also shown promising results in the prevention and treatment of metabolic disorders such as hepatitis. The asymmetric synthesis of this compound is achieved through the use of trifluoroacetic acid and nitrogen atoms. The biological properties of sodium diformylamide have not yet been fully researched but it has been found to have integrin receptor-binding properties.</p>

<p>Picotamide is a drug that belongs to the class of drugs that inhibit platelet aggregation. This drug is used in the treatment of coronary artery disease and other cardiovascular diseases. Picotamide has been shown to have pharmacological effects on the heart, such as lowering blood pressure and reducing heart rate. It also has a covalent linkage with proteins, which may be due to its ability to activate receptors for biological properties like cell proliferation or differentiation. Picotamide has been shown to prevent infectious diseases, such as septicemia, by inhibiting bacterial growth. The chemical stability of picotamide makes it an attractive candidate for use in gene therapy because it can be stored at room temperature without losing its activity.</p>

<p>Please enquire for more information about N-(4-Fluorophenyl)(5-methyl-3-phenylisoxazol-4-yl)formamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>2,6-Dimethoxy-3-nitrobenzamide is a fine chemical that is used as an intermediate in the synthesis of other compounds. This material can be used to make pharmaceuticals and research chemicals, such as antibiotics and pesticides. 2,6-Dimethoxy-3-nitrobenzamide is a versatile building block that can be used for the production of many different compounds. It has a CAS number of 55776-15-3 and has been assigned the Chemical Abstracts Service (CAS) registry number of 71887-92-8.</p>

<p>2,5-Dimethoxybenzamide is a potent inhibitor of the enzyme DECATENASE. This enzyme plays an important role in the biosynthesis of the aromatic amino acids phenylalanine and tyrosine. 2,5-Dimethoxybenzamide has been shown to have anticancer activity in vitro and in vivo. Remoxipride is a synthetic drug that competitively inhibits the action of benzodiazepines on GABA receptors by binding to them with high affinity. It was developed as an antipsychotic agent but was never marketed for this indication due to its adverse effects on motor coordination. Remoxipride has also been shown to have estrogenic activity, which may be due to its ability to bind with high affinity and inhibit the enzyme aromatase, which converts testosterone into estradiol.</p>

<p>4-Chloro-3-nitrobenzamide (4CNBA) is a potent inducer of hepatic drug metabolizing enzymes. It reacts with methyl cinnamate to form the 4-chloro-3-nitrobenzamide methyl ester and chloride ions. This reaction is catalyzed by copper, which binds to the 4CNBA molecule. The chloride ion then displaces water from the ester, producing a nitroso intermediate. This intermediate breaks down into an unstable nitrite, which in turn reacts with hydrogen peroxide to form a hydroxylamine intermediate. Hydroxylamine can then react with sulfhydryl groups to produce reactive thiols that are responsible for the induction of detoxification enzymes in the liver.<br>4CNBA has been shown to be toxic at high concentrations and is rapidly detoxified by Phase II enzymes such as glutathione S transferase, UDP glucuronosyltransferase, and N-acetyl</p>

<p>N-Ethylheptadecafluoro-N-[3-(Trimethoxysilyl)Propyl]Octanesulphonamide is a membrane filtration technology that is used to remove all organic and inorganic pollutants from water. It is effective for the removal of oils, pesticides, herbicides, detergents, antibiotics, and heavy metals. N-Ethylheptadecafluoro-N-[3-(Trimethoxysilyl)Propyl]Octanesulphonamide is also used to treat wastewater and surface water. This process can be used on large quantities of water with high efficiency. The use of this process can be beneficial for the health of humans, animals, and the environment.</p>

<p>2,5-Dichlorobenzamide is a halogenated compound that inhibits topoisomerase and proteasome activity. It has been shown to be cytotoxic against cancer cells in vitro. 2,5-Dichlorobenzamide can also inhibit the growth of tuberculosis bacteria and may be used as an operational agent for weed control. The safety profile of this drug has not yet been fully determined. 2,5-Dichlorobenzamide is available in two crystalline forms, both of which are active with different degrees of potency.<br>2,5-Dichlorobenzamide is a hybridization inhibitor that inhibits the enzyme DNA gyrase and proteasome activity. It binds to bacterial 16S ribosomal RNA and inhibits protein synthesis, leading to cell death by inhibiting the production of proteins vital for cell division.</p>

<p>3-Amino-4-methylbenzamide is an interchemical that can be utilized to synthesize naphthol. 3-Amino-4-methylbenzamide is an amide that has been shown to have a molecular modeling structure of a conformation. The interaction of 3-amino-4-methylbenzamide with the P38 kinase enzyme has been shown to inhibit the activity of this enzyme, which may lead to its use as a drug for the treatment of inflammation.</p>

<p>L-Pyroglutamic acid-beta-naphthylamide is a cell nucleus pressor that has been shown to stimulate locomotor activity in rats. It is a highly selective agonist at the 5-HT2 receptor, which is involved in the regulation of energy metabolism and feeding behaviour. L-Pyroglutamic acid-beta-naphthylamide also stimulates cholinergic and serotonergic systems. This drug also inhibits bacterial growth by binding to the receptor site on bacterial cell nuclei, thereby preventing DNA synthesis and locomotor activity. L-Pyroglutamic acid-beta-naphthylamide is an antimicrobial agent that can be used to treat infections caused by bacteria resistant to erythromycin. The antimicrobial effect of this drug is due to its ability to bind to the receptor site on bacterial cell nuclei, thereby preventing DNA synthesis and locomotor activity.</p>

<p>Pantethine is a dietary supplement, which is a derivative of pantothenic acid, sourced from vitamin B5. As a biologically active compound, it undergoes conversion to pantetheine, which then forms coenzyme A (CoA) and acyl-carrier proteins. This conversion is critical, as CoA is an essential cofactor involved in numerous biochemical reactions that are integral to fatty acid metabolism, among other processes.</p>

<p>Please enquire for more information about N-(2,5-dimethylphenyl)(3-chlorobenzo[b]thiophen-2-yl)formamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about 4-Methyl-N-[3-(Trifluoromethyl)Phenyl]Benzenesulfonamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>N,N'-Dimethyl benzamide (DMAB) is an aryl halide that reacts with hydrogen to form the corresponding carbonyl group. The reaction solution of DMAB and hydrogen gas produces a chemical structure that resembles a hydrogen bond. DMAB has been shown to have anti-inflammatory effects in animals with inflammatory diseases. It has also been studied for its ability to inhibit the formation of amyloid plaque, which is associated with Alzheimer's disease. In addition, DMAB has been shown to have therapeutic effects against boron nitride and amides.<br>The crystal structure of DMAB can be found in both crystalline polymorphs: monoclinic and triclinic. The triclinic form is stable at room temperature and pressure, while the monoclinic form is only stable at higher temperatures. The monoclinic form is more soluble than the triclinic form, as it contains fewer hydrogen bonds between</p>

<p>2-[Ethyl-[2-(3-hydroxy-2,6-dimethyl-anilino)-2-oxo-ethyl]amino]-N-(3-hydroxy-2,6-dimethylphenyl)acetamide is a reaction component that is used in the synthesis of complex compounds. It is a versatile building block and useful intermediate for the synthesis of fine chemicals. This chemical has been shown to be an effective reagent for the preparation of high quality research chemicals. CAS No. 2200280-96-0</p>

<p>N-[(4-Amino-2-methylpyrimidin-5-yl)methyl]formamide (NAMPT) is a triazolo compound that inhibits the ATP binding cassette transporter and blocks the uptake of uridine and pyrimidine compounds. It also inhibits inorganic pyrophosphatase, which is an enzyme that catalyzes the hydrolysis of pyrophosphate to inorganic phosphate. NAMPT has been shown to be a substrate for hypochlorous acid production in neutrophils, suggesting it may play a role in the regulation of oxidative stress. Chemical biology studies have demonstrated that NAMPT plays a physiological function as an intermediate in vitamin B1 biosynthesis.</p>

<p>L-Aspartic acid beta-naphthylamide is a dietary amino acid that is metabolized to oxaloacetate in the liver. This metabolite is then converted to aspartate and glutamate, which are both important for brain functions. L-Aspartic acid beta-naphthylamide has been shown to have regulatory effects on peptide hormones, such as inhibiting the synthesis of angiotensin II and vasopressin in rats. L-Aspartic acid beta-naphthylamide also has anti-cancer properties, which may be due to its ability to inhibit the growth of cancer cells by hydrolyzing proteins and enzymes involved in fatty acid synthesis.</p>

<p>Please enquire for more information about N-amino-2-(4-bromo-3,5-dimethylphenoxy)ethanamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about N-(4-methylthio(3H-2,3,5-triazolyl))-3-phenylprop-2-enamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>N-[2-(p-Cinnamylamino)ethyl]-5-isoquinolone sulfonamide is a high quality chemical that can be used as a reagent, complex compound, and useful intermediate. N-[2-(p-Cinnamylamino)ethyl]-5-isoquinolone sulfonamide is a fine chemical that is useful in the production of speciality chemicals. It can be used as a versatile building block and reaction component to produce various compounds.</p>

<p>Voltage-gated sodium channel blocker</p>

<p>2-Bromo-N-[2-[7-Chloro-5-(2-fluorophenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]ethyl]acetamide is a benzodiazepine derivative that binds to the benzodiazepine receptor and is also a calcium antagonist. It has been used in clinical studies as a chronic treatment for cancer and as an anticonvulsant. 2BBA acts on benzodiazepine receptors to inhibit the release of gamma aminobutyric acid (GABA) by binding to GABA A receptors. This prevents the binding of GABA with these receptors and leads to sedation and muscle relaxation. Flunitrazepam, which is chemically similar to 2BBA, is also used as a sedative and hypnotic drug. 2BBA has affinity constants that are between 50 nM and 100 μM for benzodiazepine binding sites, while its</p>

<p>4-Amino-N-benzylbenzamide is a high quality chemical that is an intermediate in the synthesis of other useful compounds. It is a reagent for organic synthesis, and has many uses as a complex compound, as well as being a useful building block for more complicated molecules. 4-Amino-N-benzylbenzamide is also used as a speciality chemical in research labs, and can be used as a versatile building block to make different products.</p>

<p>2-Amino-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide is a fine chemical that is used as a building block in organic synthesis. It is a versatile intermediate for the synthesis of other compounds and can be used to make a variety of useful scaffolds. 2-Amino-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide has been used in research and development of pharmaceuticals, agrochemicals, herbicides, and other compounds.</p>

<p>3-Nitro-4-methoxybenzamide is a versatile building block that belongs to the group of fine chemicals. It is a reagent that is used in the synthesis of complex compounds. 3-Nitro-4-methoxybenzamide has been shown to be an effective intermediate for the synthesis of pharmaceuticals, such as antibiotics and immunosuppressants. This compound also has high quality and can be used as a scaffold for other chemical syntheses.</p>

<p>Eliglustat is an oral medication used as a substrate reduction therapy for Gaucher disease type 1, which is an inherited lysosomal storage disorder. This product is a small-molecule inhibitor derived via chemical synthesis. Its primary mode of action involves the selective inhibition of glucosylceramide synthase, an enzyme responsible for the first committed step in glycosphingolipid biosynthesis. By reducing the production of glucosylceramide, eliglustat decreases the substrate accumulation that contributes to the pathophysiology of Gaucher disease.</p>

<p>M03354 - Fmoc-D-Asn(Trt)-OH</p>